{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T02:30:09Z","timestamp":1749090609215,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003484","name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic liver diseases, especially chronic hepatitis, are a known risk factor for the development of liver cancer. However, the risk of total cancer development and malignant potential from these diseases is largely unknown. Systematic data on the risk of cancer development from these diseases are missing. Therefore, the goal of this study is to analyze the risk of total cancer development in chronic liver diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort of 15,706 patients with chronic hepatitis and 15,706 patients without hepatitis were matched by propensity scoring from outpatient practices in Germany over a period of 15\u00a0years. Cox regression models were conducted to study the association between alcoholic hepatitis, autoimmune hepatitis, hepatitis B, hepatitis C and cancer incidence, including liver, other digestive organs, skin, prostate, breast and lymphoid and hematopoietic tissue cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Within 10\u00a0years of the index date, 19.3% of patients with alcoholic hepatitis and 13.4% of non-hepatitis individuals were diagnosed with cancer (log-rank <jats:italic>p<\/jats:italic>\u2009=\u20090.035). These proportions were 15.0 vs. 9.9% (<jats:italic>p<\/jats:italic>\u2009=\u20090.078) for autoimmune hepatitis, 8.7 vs. 7.1% (<jats:italic>p<\/jats:italic>\u2009=\u20090.015) for hepatitis B, and 12.7 vs. 7.6% (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) for hepatitis C. In regression analyses, only alcoholic hepatitis (HR: 1.84, 95% CI 1.32\u20132.54) and hepatitis C (HR: 2.10, 95% CI 1.77\u20132.50) were significantly associated with increased risk of cancer. There was a very strong positive association between hepatitis C and liver cancer (HR: 78.2 (95% CI 10.9\u2013560.7). Furthermore, hepatitis C was associated with an increased risk of respiratory organ cancer (HR: 2.59, 95% CI 1.42\u20134.73).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study confirms the strong association between chronic hepatitis and liver cancer, but also with an overall elevated cancer risk, and especially of cancer in the respiratory tract in patients with chronic hepatitis C.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-022-04198-5","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T12:04:00Z","timestamp":1658491440000},"page":"3081-3087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in Germany"],"prefix":"10.1007","volume":"149","author":[{"given":"Sven H.","family":"Loosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sch\u00f6ler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Eschrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"4198_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.04.021","author":"RD Allison","year":"2015","unstructured":"Allison RD, Tong X, Moorman AC et al (2015) Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.021","journal-title":"J Hepatol"},{"key":"4198_CR2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i24.3556","author":"\u00c2Z de Mattos","year":"2021","unstructured":"de Mattos \u00c2Z, Debes JD, Boonstra A et al (2021) Current impact of viral hepatitis on liver cancer development: the challenge remains. World J Gastroenterol. https:\/\/doi.org\/10.3748\/wjg.v27.i24.3556","journal-title":"World J Gastroenterol"},{"key":"4198_CR3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i45.12896","author":"S Fiorino","year":"2015","unstructured":"Fiorino S, Bacchi-Reggiani L, De Biase D et al (2015) Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: a systematic review. World J Gastroenterol. https:\/\/doi.org\/10.3748\/wjg.v21.i45.12896","journal-title":"World J Gastroenterol"},{"key":"4198_CR4","unstructured":"Global progress report on HIV, viral hepatitis and sexually transmitted infections (2021) Accountability for the global health sector strategies 2016\u20132021: actions for impact. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"4198_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4352-6","author":"TH Ha","year":"2017","unstructured":"Ha TH, Kim BG, Jeong D et al (2017) Alcoholic liver disease is associated with an increased risk of gastric cancer. Dig Dis Sci. https:\/\/doi.org\/10.1007\/s10620-016-4352-6","journal-title":"Dig Dis Sci"},{"key":"4198_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03922-5","author":"L Jacob","year":"2022","unstructured":"Jacob L, Kalder M, Kostev K (2022) Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-022-03922-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"4198_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13577","author":"H Kamal","year":"2021","unstructured":"Kamal H, Fornes R, Simin J et al (2021) Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: a systematic review and meta-analysis of longitudinal studies. J Viral Hepat. https:\/\/doi.org\/10.1111\/jvh.13577","journal-title":"J Viral Hepat"},{"key":"4198_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283213046","author":"E Lanoy","year":"2009","unstructured":"Lanoy E, Dores GM, Madeleine MM et al (2009) Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS. https:\/\/doi.org\/10.1097\/QAD.0b013e3283213046","journal-title":"AIDS"},{"key":"4198_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2020.1868568","author":"X Liu","year":"2021","unstructured":"Liu X, Zhang Z, hua, Jiang F, (2021) Hepatitis B virus infection increases the risk of pancreatic cancer: a meta-analysis. Scand J Gastroenterol. https:\/\/doi.org\/10.1080\/00365521.2020.1868568","journal-title":"Scand J Gastroenterol"},{"key":"4198_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03867-1","author":"SH Loosen","year":"2021","unstructured":"Loosen SH, Kostev K, Luedde M et al (2021) Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03867-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"4198_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwab048","author":"SH Loosen","year":"2022","unstructured":"Loosen SH, Roderburg C, Jahn JK et al (2022) Heart failure and depression: a comparative analysis with different types of cancer. Eur J Prev Cardiol. https:\/\/doi.org\/10.1093\/eurjpc\/zwab048","journal-title":"Eur J Prev Cardiol"},{"key":"4198_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30559","author":"P Mahale","year":"2017","unstructured":"Mahale P, Torres HA, Kramer JR et al (2017) Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study. Cancer. https:\/\/doi.org\/10.1002\/cncr.30559","journal-title":"Cancer"},{"key":"4198_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14305","author":"AH Nyberg","year":"2020","unstructured":"Nyberg AH, Sadikova E, Cheetham C et al (2020) Increased cancer rates in patients with chronic hepatitis C. Liver Int. https:\/\/doi.org\/10.1111\/liv.14305","journal-title":"Liver Int"},{"key":"4198_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00365-y","author":"B Ponvilawan","year":"2020","unstructured":"Ponvilawan B, Charoenngam N, Rujirachun P et al (2020) Chronic hepatitis C virus infection is associated with an increased risk of lung cancer: a systematic review and meta-analysis. Lung. https:\/\/doi.org\/10.1007\/s00408-020-00365-y","journal-title":"Lung"},{"key":"4198_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.05.001","author":"M Puigveh\u00ed","year":"2019","unstructured":"Puigveh\u00ed M, Moctezuma-Vel\u00e1zquez C, Villanueva A, Llovet JM (2019) The oncogenic role of hepatitis delta virus in hepatocellular carcinoma. JHEP Rep. https:\/\/doi.org\/10.1016\/j.jhepr.2019.05.001","journal-title":"JHEP Rep"},{"key":"4198_CR16","doi-asserted-by":"publisher","DOI":"10.5414\/CP203320","author":"W Rathmann","year":"2018","unstructured":"Rathmann W, Bongaerts B, Carius HJ et al (2018) Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. https:\/\/doi.org\/10.5414\/CP203320","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4198_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwab119","author":"R Sharma","year":"2022","unstructured":"Sharma R, Verna EC, Simon TG et al (2022) Cancer risk in patients with autoimmune hepatitis: a nationwide population-based cohort study with histopathology. Am J Epidemiol. https:\/\/doi.org\/10.1093\/aje\/kwab119","journal-title":"Am J Epidemiol"},{"key":"4198_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280404","author":"HT S\u00f8rensen","year":"1998","unstructured":"S\u00f8rensen HT, Friis S, Olsen JH et al (1998) Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. https:\/\/doi.org\/10.1002\/hep.510280404","journal-title":"Hepatology"},{"key":"4198_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048109","author":"FH Su","year":"2012","unstructured":"Su FH, Chang SN, Chen PC et al (2012) Positive association between hepatitis C infection and oral cavity cancer: a Nationwide Population-Based Cohort Study in Taiwan. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0048109","journal-title":"PLoS ONE"},{"key":"4198_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199306243282501","author":"H Tsukuma","year":"1993","unstructured":"Tsukuma H, Hiyama T, Tanaka S et al (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. https:\/\/doi.org\/10.1056\/nejm199306243282501","journal-title":"N Engl J Med"},{"key":"4198_CR21","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2017-0118","author":"T Tu","year":"2017","unstructured":"Tu T, B\u00fchler S, Bartenschlager R (2017) Chronic viral hepatitis and its association with liver cancer. Biol Chem. https:\/\/doi.org\/10.1515\/hsz-2017-0118","journal-title":"Biol Chem"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04198-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04198-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04198-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:05:54Z","timestamp":1688213154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04198-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4198"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04198-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The \u201cDisease Analyzer\u201d database, used for analysis, contains anonymized electronic patient records. Patient data were analyzed in aggregated form without individual data being available. An individual consent form was not obtained following national and European legislation. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}